EMA Authorised: Trulicity (dulaglutide) — Eli Lilly Nederland B.V.

View source ↗

Summary

The EMA authorised Trulicity (dulaglutide) from Eli Lilly Nederland B.V. for use in Type 2 diabetes mellitus in the European Union. The decision date is 30 Janu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TRULICITY (DULAGLUTIDE)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Eli Lilly Nederland B.V.. Decision date: 30/01/2026